Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11237-11247
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11237
Table 1 The clinical characteristics and laboratory tests of patients with coronavirus disease 2019 and psittacosis

Patient 0
Patient 1
Patient 2
Patient 3
Patient 4
Patient1
Patient2
Psittacosis (n = 6)
COVID-19 (n = 31)
P value
Age6236293226474834.00 (28.25-47.25)50.00 (32.00-66.00)0.073
SexMaleMaleFemaleFemaleMaleMaleMaleNANA0.660
Male416
Female215
Hemoglobin (g/dL); (male normal range 130-175; female normal range 115-150)124142135134163157143142.50 (134.75-158.50)a135.00 (120.00-141.00)0.054
White blood cell count (× 109/L); (normal range 3.5-9.5)7.1410.4310.0711.710.5310.2614.3610.48 (10.21-12.37)4.62 (3.31-6.17)0.000
Neutrophil count (× 109/L); (normal range 1.8-6.3)5.927.576.618.668.416.311.767.99 (6.53-9.44)2.89 (1.95-3.89)0.000
Lymphocyte count (× 109/L); (normal range 1.1-3.2)0.662.042.332.211.111.281.431.74 (1.24-2.24)1.09 (0.71-1.67)0.044
Platelet count (× 109/L); (normal range 125-350)186369249241193214204227 (201-279)183 (124-227)0.035
Eosinophilic count (× 109/L); (normal range 0.02-o.52)00.10.0100000.000 (0.000-0.325)0.100 (0.000-0.400)0.265
C-reactive protein (mg/L); (normal range 0.0-5.0)127.1712.1731.8750.5558.01112.13141.3554.28 (26.95-119.44)15.60 (4.77-47.73)0.035
Sodium (mmol/liter)NA140.91136.2134.2136.1129.7137.4136.15 (133.08-138.28)135.90 (133.40-137.40)0.857
Potassium (mmol/liter)NA4.093.423.423.944.113.523.73 (3.42-4.10)4.02 (3.58-4.37)0.302
Calcium (mmol/liter)NA2.112.282.0322.22.162.14 (2.02-2.22)1.20 (1.18-1.22)0.000
The number of detected sequences of C. psittaciNA274382254NANANANANA
Table 2 The imaging findings of patients with coronavirus disease 2019 and psittacosis

Psittacosis (n = 6)
COVID-19 (n = 13)
P value
Predominant lesion type0.221
GGO0 (0)5 (38.5)
Consolidation3 (50)5 (38.5)
Mixed GGO and consolidation3 (50)3 (23.1)
Air bronchogram6 (100)8 (61.5)0.128
Vascular enlargement1 (16.7)12 (92.3)0.003
Margin (uneasily differentiated)6 (100)8 (61.5)0.128
Reticulation5 (75)9 (69.2)1.000
Pleural effusions6 (100)1 (7.7)0.002
Craniocaudal distribution0.026
Upper lung predominant0 (0)2 (15.4)
Lower lung predominant6 (100)4 (30.8)
No craniocaudal distribution0 (0)7 (53.8)
Transverse distribution0.255
Central0 (0)0 (0)
Peripheral6 (100)9 (69.2)
No transverse distribution0 (0)4 (30.8)
Lung region distribution0.001
Unilateral6 (100)2 (15.4)
Bilateral0 (0)11 (84.6)
Number of involved lung lobes0.006
16 (100)2 (15.4)
20 (0)3 (23.1)
30 (0)0 (0)
40 (0)5 (38.5)
50 (0)5 (38.5)